ALTAREX CORP. (TSE: AXO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ALTAREX CORP. (TSE: AXO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Prescesky who wrote (245)	10/24/2000 2:24:19 PM
From: Mark J. Redmond	Read Replies (1) of 274

The wait may be over! altarex.com AltaRex Reports New OvaRex(TM) Clinical Data WALTHAM, Mass., Oct. 24 /CNW/ -- AltaRex Corp. (Toronto: AXO; OTC: ALRXF) today reported new clinical data from its double-blind placebo-controlled lead OvaRex(TM) trial for the watchful waiting indication of ovarian cancer. AltaRex Highlights Additional BrevaRex(TM) Phase I Data WALTHAM, Mass., Oct. 24 /CNW/ -- AltaRex Corp. (Toronto: AXO; OTC: ALRXF) today announced new and preliminary data from a completed Phase I clinical trial of its BrevaRex(TM) MAb demonstrating activation of cellular (T cell) immune responses

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next